跳转至内容
Merck
  • Individual differences in acute pain-induced endogenous analgesia predict time to resolution of postoperative pain in the rat.

Individual differences in acute pain-induced endogenous analgesia predict time to resolution of postoperative pain in the rat.

Anesthesiology (2015-01-13)
Christopher M Peters, Ken-Ichiro Hayashida, Takashi Suto, Timothy T Houle, Carol A Aschenbrenner, Thomas J Martin, James C Eisenach
摘要

Chronic postsurgical pain, a significant public health problem, occurs in 10 to 50% of patients undergoing major surgery. Acute pain induces endogenous analgesia termed conditioned pain modulation (CPM), and the strength of CPM preoperatively predicts the likelihood of chronic postsurgical pain. The relation between CPM and recovery from surgery has not been examined in preclinical models. CPM was assessed in individual rats and correlated with each animal's time course of recovery of hypersensitivity after partial spinal nerve ligation. The role of descending noradrenergic pathways in the spinal cord to mechanisms of CPM and recovery was tested using idazoxan to block noradrenergic receptors or antidopamine β-hydroxylase-conjugated saporin to ablate these pathways. Behavioral hypersensitivity, static weight bearing, and spinal glial activation were measured after partial spinal nerve ligation. The strength of CPM varied over two-fold between individuals and was directly correlated with the slope of recovery from hypersensitivity after surgery (P < 0.0001; r = 0.660). CPM induced the release of norepinephrine in the spinal cord and was partially blocked by intrathecal idazoxan or dopamine β-hydroxylase-saporin. Dopamine β-hydroxylase-saporin also slowed recovery and enhanced spinal glial activation after partial spinal nerve ligation surgery. Ongoing activation of these pathways was critical to sustained recovery because intrathecal dopamine β-hydroxylase-saporin given 7 weeks after recovery reinstituted hypersensitivity, while having no effect in animals without previous surgery. Collectively, these studies provide a clear back-translation from clinical observations of CPM and chronic postsurgical pain and suggest that the ability to engage ongoing descending endogenous noradrenergic signaling may be critical in determining time course of recovery from hypersensitivity after surgery.

材料
货号
品牌
产品描述

Sigma-Aldrich
纯乙醇, 200 proof, for molecular biology
Sigma-Aldrich
纯乙醇, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
纯乙醇, 200 proof, HPLC/spectrophotometric grade
Sigma-Aldrich
纯乙醇, 200 proof, meets USP testing specifications
Sigma-Aldrich
纯乙醇, 190 proof, for molecular biology
Sigma-Aldrich
邻二甲苯, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
纯乙醇, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
酒精, ACS reagent, prima fine spirit, without additive, F15 o1
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
邻二甲苯, reagent grade, ≥98.0%
Sigma-Aldrich
辣椒素, ≥95%, from Capsicum sp.
Sigma-Aldrich
纯乙醇, 190 proof, ACS spectrophotometric grade, 95.0%
Supelco
邻二甲苯, suitable for HPLC, 98%
Sigma-Aldrich
酒精, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
辣椒素, natural
Supelco
Ethanol 溶液, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
酒精, puriss. p.a., absolute, ≥99.8% (GC)
Sigma-Aldrich
酒精, purum, absolute ethanol, denaturated with 2% 2-butanone, A15 MEK1, ≥99.8% (based on denaturant-free substance)
Supelco
10% (v/v) 乙醇标准品, 10 % (v/v) in H2O, analytical standard
Sigma-Aldrich
纯乙醇, 190 proof, meets USP testing specifications
USP
无水酒精, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
辣椒素, from Capsicum sp., ≥50% (HPLC)
Sigma-Aldrich
邻二甲苯, anhydrous, 97%
USP
辣椒素, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
酒精, JIS special grade, 94.8-95.8%
Sigma-Aldrich
酒精, ≥99.5%, suitable for HPLC
Supelco
邻二甲苯, analytical standard
Sigma-Aldrich
酒精, ≥99.5%
Supelco
无水乙醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
7-二乙氨基-3-(4-马来酰亚胺苯基)-4-甲基香豆素, suitable for fluorescence, BioReagent, ≥90% (HPCE)